脑下核深层大脑刺激改善了帕金森病中的动力震
Iwan Grooters1, Bart E K S Swinnen2, Yarit Wiggerts1,3
1Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, the Netherlands.
Movement disorders clinical practice
|February 22, 2026
概括
亚thalamic核的深度大脑刺激 (DBS) 显著改善了所有帕金森病子类型,包括动力. 这种治疗为休息,姿势和运动震提供了实质性的缓解,完全解决的比例很高.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 运动障碍 运动障碍
背景情况:
- 休息震是帕金森病 (PD) 的标志,但动作震,特别是动力震,也会影响患者.
- 脑下核深度大脑刺激 (STN-DBS) 已被确立为PD运动症状,但其对动作震的影响尚不清楚.
研究的目的:
- 评估STN-DBS在改善帕金森病患者的休息,姿势和运动震方面的疗效.
- 专门研究STN-DBS对动力震的有效性,这是一个不太了解的亚型.
主要方法:
- 从接受双边STN-DBS的帕金森病患者的数据分析.
- 使用运动障碍学会统一的帕金森病评分表 (MDS-UPDRS) 的评估OFF-药物,OFF和ON-刺激,手术后6-12个月.
- 统计分析包括威尔科克森签名等级测试,效果大小计算,灵敏度分析和系统文献综述.
主要成果:
- 双边STN-DBS显示所有子类型 (休息,姿势,动力) 的显著改善 (P < 0.001).
- 在所有震亚型中观察到非常大的效应大小 (科恩d>1.00).
- 平均改善百分比是相似的:休息 (71.3%),姿势 (64.6%) 和运动 (65.1%). 完全震分辨率在各个亚型中也是一致的 (50.2%-55.8%).
结论:
- 双边STN-DBS有效地改善了帕金森病患者的所有震亚型.
- 该疗法在休息,姿势和运动震方面表现出同等的有效性,这表明在PD中对震管理有广泛的益处.
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K


